Clonidine in neuropsychiatric disorders: A review

Reuven Sandyk, Mark A. Gillman, Robert P. Iacono, Colin R. Bamford

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

We describe the basic pharmacological principles underlying the activity of the alpha2-adrenergic receptor agonist clonidine, including its interactions with the cholinergic, histaminergic, serotoninergic, endorphinergic and possibly dopaminergic systems. The use of clonidine for the therapy of various neuropsychiatric indications in which it appears to be beneficial is described. These conditions include migraine, Korsakoff's psychosis, Tourette's syndrome, withdrawal states, tardive dyskinesia, essential tremor, neuroleptic-induced akathisia, neurogenic bladder, idiopathic orthostatic hypotension, paroxysmal localised hyperhydrosis, diabetic neuropathy and stiff-man syndrome. The need for long term evaluation of this agent in some of these diseases is stressed.

Original languageEnglish (US)
Pages (from-to)205-215
Number of pages11
JournalInternational Journal of Neuroscience
Volume35
Issue number3-4
DOIs
StatePublished - Jan 1 1987

Keywords

  • Clonidine
  • Neuropsychiatric disorders

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Clonidine in neuropsychiatric disorders: A review'. Together they form a unique fingerprint.

  • Cite this